Case Western Reserve University Partners with Q2 Pharma to Treat Drug-Resistant Superbugs

Case Western Reserve University and Q2 Pharma, an Israeli biopharmaceutical company, sign a two-year option to license small molecule, antivirulence technology to treat bacterial infections, such as MRSA.

Read More  >